1. Monoclonal Antibody Targeting the HA191/199 Region of H1N1 Influenza Virus Mediates the Damage of Neural Cells.
- Author
-
Guo CY, Feng Q, Yan LT, Xie X, Liang DY, Li Y, Feng YM, Sun LJ, and Hu J
- Subjects
- Antibodies, Viral chemistry, Antibodies, Viral immunology, Cell Line, Tumor, Humans, Mutagenesis, Site-Directed, Neurons pathology, Protein Domains, Antibodies, Monoclonal, Murine-Derived chemistry, Antibodies, Monoclonal, Murine-Derived immunology, Hemagglutinin Glycoproteins, Influenza Virus chemistry, Hemagglutinin Glycoproteins, Influenza Virus genetics, Hemagglutinin Glycoproteins, Influenza Virus immunology, Influenza A Virus, H1N1 Subtype chemistry, Influenza A Virus, H1N1 Subtype genetics, Influenza A Virus, H1N1 Subtype immunology, Molecular Dynamics Simulation, Neurons metabolism
- Abstract
Vaccination is the most effective mean of preventing influenza virus infections. However, vaccination-induced adverse reactions of the nervous system, the causes of which are unknown, lead to concerns on the safety of influenza A vaccine. In this study, we used flow cytometry, cell ELISA, and immunofluorescence to find that H1-84 monoclonal antibody (mAb) against the191/199 region of the H1N1 influenza virus hemagglutinin (HA) protein binds to neural cells and mediates cell damage. Using molecular simulation software, such as PyMOL and PDB viewer, we demonstrated that the HA191/199 region maintains the overall structure of the HA head. Since the HA191/199 region cannot be removed from the HA structure, it has to be altered via introducing point mutations by site-directed mutagenesis. This will provide an innovative theoretical support for the subsequent modification the influenza A vaccine for increasing its safety.
- Published
- 2021
- Full Text
- View/download PDF